Jun 08, 2023 / 01:40PM GMT
Ryan Daniels - William Blair & Company LLC - Analyst
And I'm going to go ahead and get started. Good morning, everyone. Welcome to day three of our 43rd Annual Growth Stock Conference.
For those of you who I've not yet met, my name is Ryan Daniels. I'm the Healthcare Services and IT Analyst here at Blair. And it's my great pleasure to introduce the speaker this morning, Will Febbo, who is the CEO of OptimizeRx.
Couple of quick logistical items. I'm required to remind everyone that our disclosures are available at williamblair.com. (Conference Instructions) So again, really pleased to have OptimizeRx back. Once again, our conference and happy to have Will here. Andy D'Silva, who runs Investor Relations, is also upfront.
I mentioned, Will is the CEO. He really is not the founder but a re-founder of the company as well. He's done a great job over the years coming in really reshaping the growth algorithm, bring in a new management team, in driving the value both for pharmaceutical partners and for providers and patients.
So an exciting growth story when we think has a
OPTIMIZERx Corp at William Blair Growth Stock Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot